Virtus LifeSci Biotech Clinical Trials ETF
18 hedge funds and large institutions have $3.06M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
LPL Financial
San Diego,
California
|
$357K |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$0 |
3 |
3
Wells Fargo
San Francisco,
California
|
$0 |
4 |
4
UBS Group
Zurich,
Switzerland
|
$35.4K |